Raloxifene doesn’t hike breast density | Science News


Raloxifene doesn’t hike breast density

5:08pm, January 24, 2001

Dense breast tissue can obscure abnormal growths, making it harder for physicians to analyze mammograms. According to two new studies, hormone-replacement therapy that includes estrogen can make breast tissue more dense, while the use of raloxifene, an estrogen-replacement drug, does not.

Researchers at the Group Health Cooperative of Puget Sound in Seattle analyzed pairs of density readings, taken 2 years apart, from 5,212 postmenopausal women. Those who had started taking estrogen and progesterone between the mammograms were more than twice as likely to show a significant rise in density as were women not using hormone therapy.

Those who stopped taking hormones between mammograms were nearly twice as likely as nonusers to show a drop in density. The results appear in the Jan. 10, 2001 Journal of the American Medical Association.

This article is available only to subscribing members. Join the Society today or Log in.

Get Science News headlines by e-mail.

More from Science News